NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday

NeueHealth (NYSE:NEUE - Get Free Report) is projected to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Investors that wish to listen to the company's conference call can do so using this link.

NeueHealth Price Performance

NEUE opened at $6.77 on Thursday. The business has a 50 day simple moving average of $7.32 and a 200-day simple moving average of $5.99. The stock has a market capitalization of $56.09 million, a P/E ratio of -0.13 and a beta of 0.56. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.73.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reduced their price objective on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a report on Monday, December 9th.

Insider Buying and Selling

In other news, CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares of the company's stock, valued at $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO George Lawrence Mikan III sold 16,803 shares of NeueHealth stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total value of $70,236.54. Following the completion of the sale, the chief executive officer now directly owns 83,029 shares of the company's stock, valued at approximately $347,061.22. This represents a 16.83 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 90,848 shares of company stock valued at $608,244. 64.30% of the stock is owned by insiders.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Remove Ads